AI assistant
Sudeep Pharma Limited — Call Transcript 2026
Feb 7, 2026
59914_rns_2026-02-07_82f20dc1-ed2d-42e1-a0c9-c06915d024fa.pdf
Call Transcript
Open in viewerOpens in your device viewer
Date: 7[th] February, 2026
==> picture [152 x 86] intentionally omitted <==
To,
National Stock Exchange of India Limited BSE Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Bandra Kurla Dalal Street, Mumbai – 400001 Complex, Bandra (E), Mumbai – 400051 Scrip Code: 544619 Scrip Symbol- SUDEEPPHRM
Sub: Re-schedule of Earnings Call with Analysts/Investors on 09[th] February 2026 at 11:00 a.m.
Ref: Regulation 30 of the SEBI Listing Regulations, 2015
Dear Sir/Ma’am,
This has reference to our earlier intimation on 2[nd] February 2026 regarding “Earnings Call”; this is to inform that the “Earnings Call” of the Company with Analysts/Investors to discuss the operational & financial performance for the quarter and nine ended on December 31, 2025, is re-scheduled as below:
Day & Date: Monday, 09[th] February 2026
Time: 11:00 a.m., IST
Registration Link and Access numbers: As per Annexure
Copy of re-scheduled Earnings Call invite is annexed herewith and is also hosted on our website https://www.sudeeppharma.com/.
Kindly take the same on record.
Thanking You.
For Sudeep Pharma Limited
Digitally signed by DIMPLE ASHWINBHAI MEHTA DIMPLE ASHWINBHAI DN: cn=DIMPLE ASHWINBHAI MEHTA, c=IN, st=Gujarat, o=Personal, title=8748, MEHTA serialNumber=be901a7b4cfd5ff4b6e3310581e678582e8fcab3536586c4a365ba53eccbf1a6 Date: 2026.02.07 12:26:37 +05'30'
Dimple Mehta Company Secretary & Compliance Officer M. No.: F13184
ENCL: A/a
CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: [email protected]
==> picture [74 x 64] intentionally omitted <==
==> picture [90 x 60] intentionally omitted <==
==> picture [133 x 47] intentionally omitted <==
Sudeep Pharma Limited Conference Call
Monday, 9 February 2026 at 11:00am IST
We are organising a conference call with the management of Sudeep Pharma Limited, to discuss the company’s business strategy and outlook post the declaration of its Q3FY26 results.
| Mr. Sujit Bhayani,Managing Director | |||
|---|---|---|---|
| Management participants | Mr. Shanil Bhayani,Director | ||
| Mr. Ketan Vyas,Chief Financial Officer | |||
| Date / Time | Monday, 9 February 2026 at 11:00am IST (HK/Singapore – 1:30pm, UK – 5:30am, New York – 12:30am) |
||
| Diamond Pass | Event Link |
||
| India | |||
| Universal Access | +91 22 6280 1259 / +91 22 7115 8160 | ||
| International | Toll-free number | ||
| USA | 18667462133 | ||
| UK | 08081011573 | ||
| Singapore | 8001012045 | ||
| HongKong | 800964448 |
For further information, please contact:
Ranjit Cirumalla | Tel: +91 22 4646 4654 | Email: [email protected]
IIFL – 24th floor, One Lodha Place, Senapati Bapat Marg, Lower Parel (W), Mumbai 400 013, Tel: (91-22) 4646 4600, Fax: (91-22) 4646 4700